Detailansicht

Wissensnetz

Person

Erwin Blessing (1966-)

Kardiologe

Name	Erwin Blessing
Zeit	1966- (Lebensdaten)
Ort	Heidelberg (Wirkungsort) Deutschland
Geschlecht	männlich
Akademischer Grad bzw. Titel	Priv.-Doz. Dr. med.
Beruf	Kardiologe (charakteristischer Beruf)
Variante	Erwin Alexander Blessing E. Blessing E. A. Blessing
Beziehung	Universität Heidelberg
Weitere Angaben	Angiologie, Medizinische Universitäts- und Poliklinik Heidelberg
Datensatztyp	Person
GND-Nummer	1054407673
Datensatz-ID	1054407673
Beteiligt an alle anzeigen Optimized drug‐coated balloon angioplasty of the superficial femoral and proximal popliteal arteries using the Tack Endovascular System: Tack Optimized Balloon Angioplasty (TOBA) III 24‐month results in standard and long lesions Long-Term Effectiveness and Safety of Femoropopliteal Drug-Coated Balloon Angioplasty : 5-Year Results of the Randomized Controlled EffPac Trial Long-term effectiveness and safety of femoropopliteal drug-coated balloon angioplasty : : 5-year results of the randomized controlled EffPac trial Long-term outcome upon treatment of calcified lesions of the lower limb using scoring angioplasty balloon (AngioSculpt™) COMPARE: prospective, randomized, non-inferiority trial of high- vs. low-dose paclitaxel drug-coated balloons for femoropopliteal interventions PROMISE international; a clinical post marketing trial investigating the percutaneous deep vein arterialization (LimFlow) in the treatment of no-option chronic limb ischemia patient Erratum to: The effectiveness of the paclitaxel-coated Luminor® balloon catheter versus an uncoated balloon catheter in superficial femoral and popliteal arteries in preventing vessel restenosis or reocclusion: study protocol for a randomized controlled trial Directional atherectomy followed by a paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency : : twelve-month results of the DEFINITIVE AR study The effectiveness of the paclitaxel-coated Luminor® balloon catheter versus an uncoated balloon catheter in superficial femoral and popliteal arteries in preventing vessel restenosis or reocclusion: study protocol for a randomized controlled trial The effectiveness of the paclitaxel-coated Luminor® balloon catheter versus an uncoated balloon catheter in superficial femoral and popliteal arteries in preventing vessel restenosis or reocclusion: study protocol for a randomized controlled trial IL-17A influences essential functions of the monocyte/macrophage lineage and is involved in advanced murine and human atherosclerosis GDF-15 protects from macrophage accumulation in a mousemodel of advanced atherosclerosis Rosuvastatin reduces neointima formation in a rat model of balloon injury Morphologische Veränderungen nach Laserangioplastie von experimentell erzeugten fibromuskulären Plaques : Einfluss der Schockwellenreduktion

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Erwin Blessing (1966-)

Optimized drug‐coated balloon angioplasty of the superficial femoral and proximal popliteal arteries using the Tack Endovascular System: Tack Optimized Balloon Angioplasty (TOBA) III 24‐month results in standard and long lesions

Long-Term Effectiveness and Safety of Femoropopliteal Drug-Coated Balloon Angioplasty : 5-Year Results of the Randomized Controlled EffPac Trial

Long-term effectiveness and safety of femoropopliteal drug-coated balloon angioplasty : : 5-year results of the randomized controlled EffPac trial

Long-term outcome upon treatment of calcified lesions of the lower limb using scoring angioplasty balloon (AngioSculpt™)

COMPARE: prospective, randomized, non-inferiority trial of high- vs. low-dose paclitaxel drug-coated balloons for femoropopliteal interventions

PROMISE international; a clinical post marketing trial investigating the percutaneous deep vein arterialization (LimFlow) in the treatment of no-option chronic limb ischemia patient

Erratum to: The effectiveness of the paclitaxel-coated Luminor® balloon catheter versus an uncoated balloon catheter in superficial femoral and popliteal arteries in preventing vessel restenosis or reocclusion: study protocol for a randomized controlled trial

Directional atherectomy followed by a paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency : : twelve-month results of the DEFINITIVE AR study

The effectiveness of the paclitaxel-coated Luminor® balloon catheter versus an uncoated balloon catheter in superficial femoral and popliteal arteries in preventing vessel restenosis or reocclusion: study protocol for a randomized controlled trial

The effectiveness of the paclitaxel-coated Luminor® balloon catheter versus an uncoated balloon catheter in superficial femoral and popliteal arteries in preventing vessel restenosis or reocclusion: study protocol for a randomized controlled trial

IL-17A influences essential functions of the monocyte/macrophage lineage and is involved in advanced murine and human atherosclerosis

GDF-15 protects from macrophage accumulation in a mousemodel of advanced atherosclerosis

Rosuvastatin reduces neointima formation in a rat model of balloon injury

Morphologische Veränderungen nach Laserangioplastie von experimentell erzeugten fibromuskulären Plaques : Einfluss der Schockwellenreduktion